A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas

International Journal of Radiation Oncology, Biology, Physics · Elsevier

Аннотация

Publication date: 1 December 2026 Source: International Journal of Radiation Oncology*Biology*Physics, Volume 126, Issue 5 Author(s): Avery Horn, Eric Sherman, Nancy Lee, Yao Yu

Читать у издателя →

Похожие статьи